These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 807012)
1. Reduction of canine serum asparagine levels by L -asparaginase immobilized on collagen: a potential form of cancer chemotherapy. Olanoff LS; Bernath FR; Venkatasubramanian K; Joyeuse R Trans Am Soc Artif Intern Organs; 1975; 21():156-64. PubMed ID: 807012 [TBL] [Abstract][Full Text] [Related]
2. Perfusion trials with a collagen-immobilized enzyme in an extracorporeal reactor: activity, stability, and biocompatibility. Olanoff LS; Venkatasubramanian K; Bernath FR; Joyeuse R J Biomed Mater Res; 1977 Jan; 11(1):125-36. PubMed ID: 845182 [TBL] [Abstract][Full Text] [Related]
3. L-asparaginase bound to collagen membrane in an extracorporeal device: an intermittent antitumor enzyme therapy delivery system. Joyeuse R; Kim HC; Saidi P; McBride KJ; Jefferies SR; Bernath FR Surg Forum; 1976; 27(62):115-6. PubMed ID: 1019820 [No Abstract] [Full Text] [Related]
4. Use of immobilized L-asparaginase in acrylic microparticles in an extracorporeal hollow-fiber dialyzer. Edman P; Nylén U; Sjöholm I J Pharmacol Exp Ther; 1983 Apr; 225(1):164-7. PubMed ID: 6834269 [TBL] [Abstract][Full Text] [Related]
5. A new extracorporeal reactor-dialyzer for enzyme therapy using immobilized L-asparaginase. Jackson JA; Halvorson HR; Furlong JW; Lucast KD; Shore JD J Pharmacol Exp Ther; 1979 May; 209(2):271-4. PubMed ID: 439002 [TBL] [Abstract][Full Text] [Related]
6. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol. Kamisaki Y; Wada H; Yagura T; Matsushima A; Inada Y J Pharmacol Exp Ther; 1981 Feb; 216(2):410-4. PubMed ID: 7007618 [TBL] [Abstract][Full Text] [Related]
7. A Dacron wool packed-bed extracorporeal reactor: a kinetic study of immobilized Escherichia coli II L-asparaginase. KO RY; Hersh LS J Biomed Mater Res; 1976 Mar; 10(2):249-58. PubMed ID: 3508 [TBL] [Abstract][Full Text] [Related]
8. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia. Nath CE; Dallapozza L; Eslick AE; Misra A; Carr D; Earl JW Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071 [TBL] [Abstract][Full Text] [Related]
9. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481 [TBL] [Abstract][Full Text] [Related]
10. L-asparaginase bound to collagen membranes: effect of glutaraldehyde crosslinking on stabilization of catalytic activity. Jefferies SR; LaPresto P; Bernath FR J Biomed Mater Res; 1978 Jul; 12(4):491-503. PubMed ID: 98529 [TBL] [Abstract][Full Text] [Related]
12. In vivo effects of intraperitoneally injected L-asparaginase solution and L-asparaginase immobilized within semipermeable nylon microcapsules with emphasis on blood L-asparaginase, 'body' L-asparaginase, and plasma L-asparagine levels. Siu Chong ED; Chang TM Enzyme; 1974; 18(3):218-39. PubMed ID: 4601662 [No Abstract] [Full Text] [Related]
13. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment. Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M; Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792 [TBL] [Abstract][Full Text] [Related]
14. Immobilization of L-asparaginase into a biocompatible poly(ethylene glycol)-albumin hydrogel: evaluation of performance in vivo. Jean-François J; D'Urso EM; Fortier G Biotechnol Appl Biochem; 1997 Dec; 26(3):203-12. PubMed ID: 9428158 [TBL] [Abstract][Full Text] [Related]
15. [X-ray microanalysis of the activity of immobilized L-asparaginase]. Ding L; Yao ZH Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Sep; 24(9):1136-9. PubMed ID: 15762544 [TBL] [Abstract][Full Text] [Related]
16. Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor. Asselin BL; Lorenson MY; Whitin JC; Coppola DJ; Kende AS; Blakley RL; Cohen HJ Cancer Res; 1991 Dec; 51(24):6568-73. PubMed ID: 1742729 [TBL] [Abstract][Full Text] [Related]
18. Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229). Haskell CM; Canellos GP; Cooney DA; Hardesty CT Cancer Chemother Rep; 1972 Oct; 56(5):611-4. PubMed ID: 4569055 [No Abstract] [Full Text] [Related]
19. Biochemical characterization and immobilization of Erwinia carotovoral-asparaginase in a microplate for high-throughput biosensing of l-asparagine. Labrou NE; Muharram MM Enzyme Microb Technol; 2016 Oct; 92():86-93. PubMed ID: 27542748 [TBL] [Abstract][Full Text] [Related]
20. Theoretical and practical considerations in the use of hemodialysis for the therapeutic removal of asparagine and other amino acids. Riley V; Spackman DH Nutr Cancer; 1981; 2(3):181-92. PubMed ID: 7346782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]